|
⚲
|
| Keyboard |
| Hastings David C
✚
|
|
|---|---|
| CIK # | 0001237401 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001237401] | |
| 4 | [0001237401] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Scynexis Inc | |
| Hastings David C | |
| Trevi Therapeutics Inc | |
| Arbutus Biopharma Corp | |
| Notable Labs Ltd | |
| Entasis Therapeutics Holdings Inc | |
| Unilife Corp | |
| Incyte Corp |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Trevi Therapeutics Inc TRVI
Stock Option (right to buy) · derivative
|
2026-01-08 | Grant | 375,000 | $0.00 | |
|
Scynexis Inc SCYX
Stock Option · derivative
|
2025-06-26 | Grant | 23,000 | $0.00 | |
|
Scynexis Inc SCYX
Common Stock
|
2025-06-26 | Grant | 23,000 | $0.00 | |
|
Arbutus Biopharma Corp ABUS
Common Shares
|
2025-02-14 | Grant | 90,100 | $0.00 | |
|
Arbutus Biopharma Corp ABUS
Stock Option (Right to Buy) · derivative
|
2025-02-14 | Grant | 365,800 | $0.00 | |
|
Arbutus Biopharma Corp ABUS
Common Shares
|
2025-02-04 | Sell | 22,183 | $3.28 | 72,760 |
|
Scynexis Inc SCYX
Stock Option · derivative
|
2024-06-20 | Grant | 23,000 | $0.00 | |
|
Scynexis Inc SCYX
Common Stock
|
2024-06-20 | Grant | 23,000 | $0.00 | |
|
Arbutus Biopharma Corp ABUS
Common Shares
|
2024-02-02 | Sell | 9,593 | $2.31 | 22,160 |
|
Arbutus Biopharma Corp ABUS
Common Shares
|
2024-02-01 | Grant | 112,500 | $0.00 | |
|
Arbutus Biopharma Corp ABUS
Stock Option (Right to Buy) · derivative
|
2024-02-01 | Grant | 450,000 | $0.00 | |
|
Scynexis Inc SCYX
Common Stock
|
2023-06-15 | Grant | 10,000 | $0.00 | |
|
Scynexis Inc SCYX
Stock Option · derivative
|
2023-06-15 | Grant | 10,000 | $0.00 | |
|
Arbutus Biopharma Corp ABUS
Common Shares
|
2023-02-01 | Grant | 79,000 | $0.00 | |
|
Arbutus Biopharma Corp ABUS
Stock Option (Right to Buy) · derivative
|
2023-02-01 | Grant | 316,000 | $0.00 | |
|
Entasis Therapeutics Holdings Inc ETTX
Stock Option (right to buy) · derivative
|
2022-07-11 | Other | 26,583 | $0.00 | |
|
Entasis Therapeutics Holdings Inc ETTX
Common Stock
|
2022-07-11 | Disposed to issuer | 27,500 | $2.20 | 60,500 |
|
Entasis Therapeutics Holdings Inc ETTX
Stock Option (right to buy) · derivative
|
2022-07-11 | Other | 11,000 | $0.00 | |
|
Entasis Therapeutics Holdings Inc ETTX
Common Stock
|
2022-07-07 | Tender | 22,000 | $2.20 | 48,400 |
|
Scynexis Inc SCYX
Common Stock
|
2022-06-17 | Grant | 10,000 | $0.00 | |
| showing 20 of 108 most recent transactions | |||||